Cornered in a part of Downtown Los Angeles swamped in contemporary art museums and performance centers, REDCAT has become a ...

A new research paper reframes the simulation hypothesis, asking whether reality could be simulated and what science can test.

The new major version with a new JIT compiler, a revised parallelization API, and a maturing type system paves the way for ...

The lack of gains in productivity from AI could stall adoption and burst the economic bubble. Is there a rational explanation?

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

While SIMPLE IRAs are in some ways similar to their cousins, traditional and Roth IRAs, they also share some features with workplace retirement plans such as 401(k)s. Understanding your plan's rules ...

Instead of a complicated smartphone, you may be better off with a no-nonsense and accessible simple mobile phone that gives you all the essentials without any fuss. The best simple mobiles are ...

Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. Eric's career includes extensive work ...